Hepatitis%20C%20Genotype%202
Showing 26 - 50 of >10,000
Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)
Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Jul 9, 2021
Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Jul 9, 2021
Acute Coronary Syndrome, CYP2C19 Polymorphism Trial in Nieuwegein (Clopidogrel)
Recruiting
- Acute Coronary Syndrome
- CYP2C19 Polymorphism
-
Nieuwegein, Utrecht, NetherlandsSt. Antonius Hospital
Jun 27, 2023
Hepatitis C Infection, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir)
Completed
- Hepatitis C Infection
- Hepatitis C Virus
- (no location specified)
Jul 28, 2021
Hepatitis C Trial in Seoul
Completed
- Hepatitis C
-
Seoul, Korea, Republic ofLocal Institution
Jan 6, 2022
Atrial Fibrillation, Coronary Artery Disease Trial (Rivaroxaban)
Not yet recruiting
- Atrial Fibrillation
- Coronary Artery Disease
- (no location specified)
Oct 22, 2023
Hepatitis C, Chronic Trial in Carlsbad (ISIS 14803)
Completed
- Hepatitis C, Chronic
- ISIS 14803
-
Carlsbad, CaliforniaIsis Pharmaceuticals
Dec 1, 2022
Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir)
Completed
- Chronic Hepatitis C Infection
- Compensated Cirrhosis
- (no location specified)
Jul 8, 2021
Hepatitis C, Chronic Trial (Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c)
Completed
- Hepatitis C, Chronic
- Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin
- Combination of (a) pegylated interferon alfa-2b and (b) ribavirin
- (no location specified)
Aug 24, 2020
HCV Trial in Beijing (Ravidasvir, Danoprevir, Ritonavir)
Completed
- HCV
- Ravidasvir
- +7 more
-
Beijing, Beijing, ChinaPeking University People's hospital
Jul 25, 2020
Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Virus (HCV) Infection Genotype 1
- ABT-450/r/ABT-267
- +2 more
-
Phoenix, Arizona
- +47 more
Jun 27, 2022
Hepatitis C Trial in Denver (Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV))
Terminated
- Hepatitis C
- Simeprivir (SMV)
- +2 more
-
Denver, ColoradoUniversity of Colorado Denver (Leprino Building)
Aug 16, 2021
Chronic Hepatitis C Virus Infection Trial in New Zealand, United States (telaprevir, VX-222, ribavirin)
Terminated
- Chronic Hepatitis C Virus Infection
- telaprevir
- +3 more
-
La Jolla, California
- +20 more
Sep 22, 2020
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +2 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +2 more
- (no location specified)
Jul 8, 2021
Australian Hepatitis and Risk Survey in Prisons
Recruiting
- Hepatitis C
- +2 more
- Point-of-care hepatitis C antibody test
- +5 more
-
Hume, Australian Capital Territory, Australia
- +23 more
Apr 20, 2023
Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Infection
- Compensated Cirrhosis
- ABT-450/r/ABT-267, ABT-333
- Ribavirin (RBV)
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +4 more
- (no location specified)
Jul 29, 2021
Chronic Hepatitis c, Liver Transplant Infection, Kidney Transplant Infection Trial in Taichung (grazoprevir 100 mg/ elbasvir 50
Terminated
- Chronic Hepatitis c
- +2 more
- grazoprevir 100 mg/ elbasvir 50 mg, Zepatier®
-
Taichung, Taiwan
- +1 more
Mar 14, 2021
Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)
Recruiting
- Chronic Hepatitis C Virus
- +4 more
-
Bucuresti, BUC, RomaniaAtea Study Site
Jun 15, 2023
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +4 more
- (no location specified)
Jul 8, 2021